Fifth disease - Fënnefter Krankheet
☆ An den 2022 Stiftung Warentest Resultater aus Däitschland war d'Zefriddenheet vum Konsument mam ModelDerm nëmme liicht manner wéi mat bezuelte Telemedizin Konsultatiounen.
16 Méint al mat Fënnefter Krankheet (Fifth disease) ― Béid Wangen ginn rout, wéi wa se geschloen ginn, a makulopapulär Ausschlag erschéngen um Kierper.
Erythema op béide Wangen.
References
Fifth disease , och bekannt als Erythema infectiosum, ass eng viral Infektioun verursaacht vum mënschleche Parvovirus B19. Et ass méi heefeg bei Kanner, typesch beaflosst déi tëscht 4 an 14 Joer. Symptomer fänken dacks mat engem mëllen Féiwer, Kappwéi, Halswéi, a Grippeähnlech Gefiller un. D'Kanner kënnen e markant roude Ausschlag am Gesiicht entwéckelen, ähnlech wéi slapped cheeks , zesumme mat engem Musteren Ausschlag um Kierper, Äerm a Been. Bei Erwuessener ass Gelenkschmerz eng allgemeng Beschwerde, déi Wochen no der initialer Infektioun erscheint. Notamment, ongeféier 20 bis 30% vun Erwuessener infizéiert mam Parvovirus B19 kënnen keng Symptomer weisen.
Fifth disease (erythema infectiosum) is a viral infection caused by human parvovirus B19. It is more common in children than adults and usually affects children ages 4 to 14. The disease often starts with mild fever, headache, sore throat, and other flu-like symptoms. Children can also develop a bright red rash on the face that looks like “slapped cheeks”, along with a lacy or bumpy rash on the body, arms, and legs. In adults, joint aches are a common symptom. Rash and joint symptoms may develop several weeks after infection. About 20 to 30% of adults who are infected with parvovirus B19 will not have symptoms.
Fifth disease (erythema infectiosum) is a viral infection caused by human parvovirus B19. It is more common in children than adults and usually affects children ages 4 to 14. The disease often starts with mild fever, headache, sore throat, and other flu-like symptoms. Children can also develop a bright red rash on the face that looks like “slapped cheeks”, along with a lacy or bumpy rash on the body, arms, and legs. In adults, joint aches are a common symptom. Rash and joint symptoms may develop several weeks after infection. About 20 to 30% of adults who are infected with parvovirus B19 will not have symptoms.
De Risiko fir parvovirus B19 vu Mamm op Puppelchen ze passéieren ass ongeféier 33%, mat ongeféier 3% vun infizéierte Fraen déi Komplikatioune bei hire Puppelcher erliewen. Wann d'Mamm virum 20 Woche vun der Schwangerschaft infizéiert gëtt, erhéijen d'Chancen vu Komplikatioune wéi Bluttproblemer a Flëssegkeetsaufbau am Kierper vum Puppelchen. Fir d'Gestioun vun dëser Krankheet unzefänken, sollte mir iwwerpréiwen ob de Patient jeemools dem Parvovirus ausgesat war, andeems mir op bestëmmten Antikörper (IgM) testen. Wann den Test keng vergaangen Belaaschtung weist, awer eng rezent Infektioun weist, brauch de Patient enk Iwwerwaachung wärend der Schwangerschaft, inklusiv reegelméissegen Ultraschallscannen fir no bestëmmte Babygesondheetsprobleemer ze kontrolléieren.
The rate of vertical transmission during maternal parvovirus B19 infection is estimated at 33%, with fetal complications occurring in 3% of infected women. Fetal complications comprising hemolysis, anemia, and nonimmune hydrops fetalis and fetal loss are more frequent when maternal infection occurs before 20 weeks of gestation. The first step in the management of this patient would be to obtain immunoglobulin (Ig) M and IgG titres against parvovirus to evaluate if the patient has had previous immunity against the disease. If results are negative for IgG but positive for IgM (ie, primary infection), this patient would need close obstetrical monitoring for the following weeks, including serial ultrasounds to rule out fetal anemia and hydrops fetalis.
The rate of vertical transmission during maternal parvovirus B19 infection is estimated at 33%, with fetal complications occurring in 3% of infected women. Fetal complications comprising hemolysis, anemia, and nonimmune hydrops fetalis and fetal loss are more frequent when maternal infection occurs before 20 weeks of gestation. The first step in the management of this patient would be to obtain immunoglobulin (Ig) M and IgG titres against parvovirus to evaluate if the patient has had previous immunity against the disease. If results are negative for IgG but positive for IgM (ie, primary infection), this patient would need close obstetrical monitoring for the following weeks, including serial ultrasounds to rule out fetal anemia and hydrops fetalis.
fënnefter krankheet (fifth disease) fänkt mat engem nidderegen Féiwer, Kappwéi, Hautausschlag, a kal-ähnlechen Symptomer, wéi eng lafend oder verstoppt Nues. Dës Symptomer passéieren, dann e puer Deeg méi spéit erschéngt den Ausschlag. Den helle roude Ausschlag erschéngt am meeschten am Gesiicht, besonnesch d'Wangen. (dohier den Numm "Schluecht Wang Krankheet"). Zousätzlech zu roude Wangen, entwéckelen d'Kanner dacks e roude, spitzen Ausschlag um Rescht vum Kierper, mat den ieweschte Waffen, Torso a Been déi meescht üblech Plazen.
D'Krankheet ass normalerweis mild, awer bei schwangere Fraen ass d'Infektioun am éischten Trimester mat Hydrops fetalis verknëppelt, wat spontan Fehlgaass verursaacht.
○ Behandlung
Keng spezifesch Behandlung ass erfuerderlech well et normalerweis mat der Zäit verbessert.